Surgery Partners reports Q1 2026 revenue up 4.5%, reaffirms full-year guidance with $3.35-$3.45B revenue forecast

Surgery Partners, a leading short-stay surgical facility operator, announced a 4.5% revenue increase to $810.9 million in Q1 2026, driven by a 4.4% rise in same-facility revenues and a slight 0.6% increase in cases. Despite a net loss of $35.9 million, the company posted an Adjusted EBITDA of $102.3 million, close to last year's level. It reaffirmed its 2026 revenue guidance of $3.35 to $3.45 billion and Adjusted EBITDA of at least $530 million, citing strong fundamentals and ongoing cost management. The company remains focused on physician recruitment and portfolio optimization to drive long-term growth and operational excellence.